New England Compounding Pharmacy, Inc.  Bankruptcy New Filing Alert: Order Regarding The Disclosure Statement With Respect To A Plan Of Reorganization Or Liquidation

On March 3, 2015, an order regarding the disclosure statement with respect to a plan of reorganization or liquidation was filed in the bankruptcy case of New England Compounding Pharmacy, Inc.  and its affiliates.

The filing was assigned docket number 1181 and is described on the court’s official docket as follows:

Order dated 3/3/2015 (I) Approving the Adequacy of the [1053] Amended Joint Disclosure Statement; (II) Approving Solicitation and Notice Procedures with Respect to Confirmation of the Plan Proponents’ First Amended Joint Plan of Reorganization; (III) Approving the Form of Various Ballots and Notices in Connection Therewith; (IV) Scheduling Certain Dates with Respect Thereto; and (V) Granting Related Relief. Confirmation hearing to be held on 5/19/2015 at 10:00 AM at Springfield Courtroom – Berkshire. Last day to Object to Confirmation 5/5/2015. See Order for Full Text. (sas)

New England Compounding Pharmacy, Inc.  filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 21, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Massachusetts. The case number for the lead bankruptcy case is 12-19882. The bankruptcy case is currently assigned to United States Bankruptcy Judge Henry Boroff. The law firm of Murtha Cullina LLP is acting as lead bankruptcy counsel to New England Compounding Pharmacy, Inc.  in the bankruptcy case.


Leave a Reply